3rd Quarter - Report — SMITH & NEPHEW, INC. for SMITH & NEPHEW, INC. (2011)

Firm

SMITH & NEPHEW, INC.

Client

SMITH & NEPHEW, INC.

Income

—

Expenses

$230,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

S. 17 -- Medical Device Access and Innovation Protection Act H.R. 436 -- Medical Device Access and Innovation Protection Act

Lobbyist	Covered position, as disclosed
PAUL SELTMAN	Spec. Assist., HHS; Counsel, Sen. Budget Com.

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: S. 17 (112th), H.R. 436 (112th)

Health Issues HCR

Reform of FDA's 510(k) process for the market clearance of medical devices. Reform of FDA's pre-market approval process for Class III devices.

Lobbyist	Covered position, as disclosed
PAUL SELTMAN	Spec. Assist., HHS; Counsel, Se. Budget Com.

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Budget/Appropriations BUD

Reauthorization of Medical Device User Fees

Lobbyist	Covered position, as disclosed
PAUL SELTMAN	Special Assist., HHS; Counsel, Sen. Budget Com.

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Durable Medical Equipment Proposed Rule for the Medicare Program published on July 8, 2011.

Lobbyist	Covered position, as disclosed
PAUL SELTMAN New	Spec. Assist, HHS; Counsel, Sen. Budget Com.

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.